肿瘤化疗患者PICC相关性上肢静脉血栓形成的危险因素考察

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (28 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the risk factors of PICC-related venous thrombosis of upper extremities in patients with tumor chemotherapy.Methods A total of 200 cases of cancer patients treated with chemotherapy in our hospital from February 10,2015 to May 10,2016 were selected as the research objects.According to the occurrence of upper extremity venous thrombosis,they were divided into observation group (with upper extremity venous thrombosis) and control group (without upper extremity venous thrombosis),100 cases in each group.The influencing factors of two groups of patients were analyzed.Results There were significant differences in age,history of venous thrombosis,chronic renal insufficiency,anticoagulant drugs,time of chemotherapy and fluid replacement,D-Dimer (D-D) level before catheterization between the two groups (P<0.05);Logistic regression analysis showed that age >60 years old,history of venous thrombosis,chronic renal insufficiency,and increased D-D level before catheterization were risk factors for PICC-related upper extremity venous thrombosis (P<0.05).Conclusion The risk factors for PICC-related upper extremity venous thrombosis in tumor chemotherapy patients are age >60 years old,history of venous thrombosis,chronic renal insufficiency,and increased D-D level before catheterization,to prevention and treatment measures for these factors can significantly reduce the incidence of venous thrombosis and ensure patient safety.

Key words： Tumor chemotherapy PICC-related upper extremity venous thrombosis Risk factors

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HUANG Zeng-guang

Cite this article:

HUANG Zeng-guang. Risk factors investigation of PICC-related upper extremity venous thrombosis in patients with tumor chemotherapy[J]. 中国当代医药, 2020, 27(2): 94-96.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I2/94

[1]	李爱华，罗容，郭坊，等.肿瘤化疗患者PICC上肢静脉血栓形成影响因素临床分析[J].中国卫生标准管理，2018，9（10）：76-77.
[2]	蒲纯，许小毛，乔力松，等.恶性肿瘤并发静脉血栓栓塞症的临床分析[J].中华老年多器官疾病杂志，2016，15（11）：810-814.
[3]	方妍.恶性肿瘤化疗患者PICC置管术后静脉血栓的形成原因及分析[J].世界临床医学，2018，12（2）：108-109.
[4]	姜明明，袁雅冬.恶性肿瘤与静脉血栓栓塞症[J].临床荟萃，2016，31（4）：373-377.
[5]	左传丽，祝明秋.肿瘤化疗患者PICC相关性上肢静脉血栓形成的危险因素分析[J].临床护理杂志，2017，16（5）：8-11.
[6]	赵立双，王绍美，李丽楠，等.肿瘤化疗患者PICC相关性静脉血栓形成的原因及护理体会[J].承德医学院学报，2016，33（2）：130-132.
[7]	杨静宜，宋永平.恶性肿瘤相关静脉血栓栓塞症研究进展[J].中华血液学杂志，2014，35（10）：97-99.
[8]	曾俊韶，叶慧芬，韦燕.恶性肿瘤合并静脉血栓形成相关危险因素及风险评估[J].现代肿瘤医学，2016，24（18）：2979-2982.
[9]	鲍轶.肿瘤患者静脉血栓的预防及治疗[J].中华全科医师杂志，2015，14（4）：306-308.
[10]	朱秀英，石小毛，邓璀敏，等.恶性肿瘤化疗患者PICC带管期间非正常拔管的原因分析[J].中华现代护理杂志，2016，22（36）：5276-5281.
[11]	张小满，宋洁，王艳艳，等.老年肿瘤化疗患者PICC置管后静脉血栓形成的危险因素及防护措施的研究进展[J].中国当代医药，2018，25（24）：37-39.
[12]	王新锋，郭康，李宁，等.比较恶性肿瘤与非恶性肿瘤静脉血栓患者肺栓塞发生率的差异[J].中国实用医药，2016，11（14）：61-62.
[13]	牛倩，江虹.肿瘤相关静脉血栓的监测进展[J].中华检验医学杂志，2016，39（10）：739-742.
[14]	邱艳，李长英.肿瘤化疗患者白细胞减少并发感染的危险因素及预防对策[J].实用临床医药杂志，2016，20（9）：57-59，63.
[15]	毕研霞，洪忠新，张立红，等.肿瘤化疗患者营养风险评估及影响因素分析[J].中国食物与营养，2018，24（3）：66-70.